Stocks to Watch Thursday, Nov. 5: ADMA Biologics, TrueBlue, Myriad Genetics, Kyndryl, Angi

By Tech & Money Press · Pre-market watchlist for Thursday, November 5, 2026

Market Setup

Stocks rallied hard on Wednesday as investors reacted to the midterm election results, with Democrats winning control of both chambers of Congress. The Dow jumped 3.0% to 53,356, the S&P 500 rose 1.6% to 7,689 and the Nasdaq gained 1.4% to 25,737. SPY closed at $766.81 (+1.7%), QQQ at $691.95 (+1.0%) and the IWM at $284.02 (+1.5%). Oil prices fell sharply and Treasury yields moved lower, while retailers and consumer stocks led the gains.

After the close, AppLovin jumped about 23% on a revenue beat and a strong fourth-quarter outlook, while Qualcomm slipped about 7%. SPY was near $767 and QQQ near $689 at 8 p.m. ET. Our list is earnings again: three after-hours gainers with fresh reports, plus two stocks that ran more than 20% on Wednesday.

1. ADMA Biologics (ADMA) – Raises profit outlook, up 28% after hours

Close: $10.48 (−5.7%) · Day range: $10.25–$11.49 · Volume: about 13.4M · After hours: ~$13.45 (+28.3%), range $10.16–$14.88, about 1.1M shares

The plasma-based biologics maker reported third-quarter revenue of $141.1 million, up 13% from the prior quarter, led by its ASCENIV immune globulin, which grew 31% from a year ago to $124.7 million. It raised its minimum adjusted EBITDA guidance to $275 million and its adjusted net income guidance to $180 million, and has bought back 16.5 million shares this year. Full-year revenue guidance of at least $530 million was only reiterated, slightly below what analysts expected, and BIVIGAM sales fell on pricing pressure. The stock had dropped almost 6% during the day before the report. The company is worth about $2.3 billion.

Our Take: This is the most liquid gapper on the list, with more than a million shares traded after hours. $14.00 (round number) is the first resistance, then $14.88 (after-hours high). On the downside, $12.00 (round number) is the first support, then $11.49 (Wednesday’s high). The after-hours range was wide, so expect a volatile open.

2. TrueBlue (TBI) – Revenue up 21%, new 52-week high after hours

Close: $9.84 (+2.6%) · Day range: $9.66–$9.97 · Volume: about 251K · After hours: ~$12.00 (+22.0%), range $9.84–$12.51, about 38K shares

The staffing company reported third-quarter revenue of $521 million, up 21% from a year ago and its fifth straight quarter of growth, with energy-sector revenue doubling. It swung to net income of $9 million from a $2 million loss, and adjusted EBITDA reached $21 million. Management expects fourth-quarter revenue to grow 20% to 24%. Gross margin slipped to 20.5% as the mix shifted toward energy work. The after-hours price is above its prior 52-week high of $11.03. The company is worth about $300 million.

Our Take: Strong numbers, but only about 38,000 shares traded after hours, so the gap needs pre-market volume to confirm it. $12.51 (after-hours high) is the first resistance, then $13.00 (round number). On the downside, $11.03 (prior 52-week high) is the first support, then $10.00 (Nov. 2 high).

3. Myriad Genetics (MYGN) – Guidance midpoint raised, up 12% after hours

Close: $6.02 (−0.3%) · Day range: $5.90–$6.20 · Volume: about 2.1M · After hours: ~$6.75 (+12.1%), range $6.02–$6.90, about 79K shares

The genetic testing company reported third-quarter revenue of $202.7 million, up 6% from the prior quarter and down 1% from a year ago, as higher revenue per test offset slightly lower test volume. It raised the midpoint of its full-year revenue guidance. In October, Myriad agreed to sell its Prenatal Health business to Labcorp for $210 million in cash, a deal that sent the stock up about 33% in one day. The stock has climbed from about $4 in mid-October. The company is worth about $575 million.

Our Take: The stock is testing its late-October high again. $6.90 (after-hours high) is the first resistance, just above the $6.77 Oct. 29 high, then $7.50 (round number). On the downside, $6.46 (Nov. 2 high) is the first support, then $6.20 (Wednesday’s high).

4. Kyndryl (KD) – Up 30% on an earnings beat

Close: $16.84 (+30.1%) · Day range: $14.62–$18.02 · Volume: about 15.0M (roughly 4x its recent average) · After hours: ~$16.89 (+0.3%)

The IT infrastructure services company reported fiscal second-quarter adjusted earnings of $0.42 per share, above the $0.38 estimate, and revenue of $3.65 billion, also slightly ahead even though sales fell about 2% from a year ago. U.S. revenue grew 9%, its adjusted EBITDA margin improved to 19.1%, and it signed 11 deals worth more than $50 million each in the quarter. Kyndryl reaffirmed its full-year revenue and free cash flow outlook. The company is worth about $3.7 billion.

Our Take: This is a day-two setup for a stock that gave back about $1.20 from its high. $18.02 (Wednesday’s high) is the first resistance, then $19.00 (round number). On the downside, $16.00 (round number) is the first support, then $15.23 (Oct. 22 high). Watch whether it holds above $16 in pre-market.

5. Angi (ANGI) – Up 21% on cost cuts and higher profit

Close: $6.84 (+21.3%) · Day range: $6.37–$7.66 · Volume: about 3.3M (roughly 5x its recent average) · After hours: ~$6.83 (−0.1%)

The home services marketplace reported third-quarter revenue of $242 million, down 8.9% from a year ago, but adjusted EBITDA rose 6.3% to $42.2 million, its highest quarterly margin since 2018. New CEO Mike Steib announced about 300 job cuts that should save $50 million to $60 million a year, and said he expects a return to growth in the second half of 2027. Revenue per lead rose almost 10%. The company is worth about $280 million.

Our Take: The stock hit $7.66 early and gave back about half of the move, so this one needs to prove itself. $7.00 (round number) is the first resistance, then $7.66 (Wednesday’s high). On the downside, $6.75 (Oct. 22 high) is the first support, then $6.38 (Nov. 2 high).

Bottom Line

Thursday’s list is another earnings day. ADMA, TrueBlue and Myriad are the after-hours gappers, while Kyndryl and Angi are the day-two names that need to hold Wednesday’s gains. Wednesday showed that gaps that hold their first support in pre-market and break resistance on volume can run hard, so focus on where each stock trades against the levels before 9:30 a.m.

Disclaimer: This article is for informational and educational purposes only and is not financial advice. Tech & Money Press is not a registered investment advisor. Trading stocks involves risk, including the loss of your investment. Do your own research and consult a licensed professional before making any investment decisions.

Sources: Price data from Webull (as of 8:00 p.m. ET, Nov. 4, 2026). Company news and earnings via Benzinga, company reports and SEC filings.